Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,055 | -30,458 | -18,901 | -9,526 | -37,923 |
| Depreciation Amortization | -1,927 | -1,794 | -1,473 | -872 | -2,949 |
| Accounts receivable | 1,226 | 1,348 | 1,327 | -343 | 7,138 |
| Other Working Capital | -751 | 960 | -2,225 | -3,438 | 3,820 |
| Other Operating Activity | 14,897 | 10,155 | 5,874 | 3,615 | 8,228 |
| Operating Cash Flow | $-27,610 | $-19,789 | $-15,398 | $-10,564 | $-21,686 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,583 | 10,101 | 6,087 | -13,592 | 58,675 |
| PPE Investments | -1,651 | -1,504 | -1,098 | -804 | -3,691 |
| Investing Cash Flow | $6,932 | $8,597 | $4,989 | $-14,396 | $54,984 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,056 | 1,644 | 1,416 | 703 | 2,143 |
| Financing Cash Flow | $2,056 | $1,644 | $1,416 | $703 | $2,143 |
| Beginning Cash Position | 46,506 | 46,506 | 46,506 | 46,506 | 11,065 |
| End Cash Position | 27,884 | 36,958 | 37,513 | 22,249 | 46,506 |
| Net Cash Flow | $-18,622 | $-9,548 | $-8,993 | $-24,257 | $35,441 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,610 | -19,789 | -15,398 | -10,564 | -21,686 |
| Capital Expenditure | -1,651 | -1,504 | -1,098 | -804 | -3,700 |
| Free Cash Flow | -29,261 | -21,293 | -16,496 | -11,368 | -25,386 |